Minnetonka, MN, United States of America

Bernhard J Hering

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Bernhard J Hering

Introduction

Bernhard J Hering is a prominent inventor based in Minnetonka, MN (US). He has made significant contributions to the field of medical science, particularly in the area of genetically modified cells and transplant tolerance. With a total of 7 patents, Hering's work has the potential to revolutionize treatments for various diseases.

Latest Patents

Hering's latest patents include groundbreaking innovations such as genetically modified cells, tissues, and organs for treating or preventing diseases. These patents disclose methods for creating genetically modified cells and non-human animals. Another notable patent is focused on transplant tolerance induction with a carbodiimide treated tolerizing vaccine. This patent relates to compositions and systems designed to induce immune tolerance for transplanted cells, organs, or tissues in transplant recipients. It also provides methods for making and administering tolerizing vaccines or preparatory regimens.

Career Highlights

Throughout his career, Hering has worked with esteemed organizations such as the University of Minnesota and Diabetes-Free Inc. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Hering has collaborated with notable colleagues, including Christopher Burlak and Sabarinathan Ramachandran. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Bernhard J Hering's contributions to the field of medical science through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in disease treatment and transplant tolerance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…